- Correlation of Ciprofloxacin Resistance with the AdeABC Efflux System in Acinetobacter baumannii Clinical Isolates
-
Ardebili A, Lari AR, Talebi M
- KMID: 2129568
- Ann Lab Med.
- 2014 Nov;34(6):433-438.
- doi: 10.3343/alm.2014.34.6.433
BACKGROUND: Acinetobacter baumannii is one of the most important pathogens capable of colonization in burn patients, leading to drug-resistant wound infections. This study evaluated the distribution of the AdeABC efflux... -
- CITED
-
- Close
- SHARE
-
- Close
- In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment
-
Kim Y, Bae IK, Jeong SH, Yong D, Lee K
- KMID: 2366331
- Yonsei Med J.
- 2015 Jul;56(4):928-934.
- doi: 10.3349/ymj.2015.56.4.928
PURPOSE: Colistin resistance in Acinetobacter baumannii (A. baumannii) is mediated by a complete loss of lipopolysaccharide production via mutations in lpxA, lpxC, and lpxD gene or lipid A modifications via... -
- CITED
-
- Close
- SHARE
-
- Close
- In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
-
Park GC, Choi JA, Jang SJ, Jeong SH, Kim CM, Choi IS, Kang SH, Park G, Moon DS
- KMID: 2373511
- Ann Lab Med.
- 2016 Mar;36(2):124-130.
- doi: 10.3343/alm.2016.36.2.124
BACKGROUND: Acinetobacter baumannii infections are difficult to treat owing to the emergence of various antibiotic resistant isolates. Because treatment options are limited for multidrug-resistant (MDR) A. baumannii infection, the discovery... -
- CITED
-
- Close
- SHARE
-
- Close
- In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
-
Lee H, Roh KH, Hong SG, Shin HB, Jeong SH, Song W, Uh Y, Yong D, Lee K
- KMID: 2373513
- Ann Lab Med.
- 2016 Mar;36(2):138-144.
- doi: 10.3343/alm.2016.36.2.138
BACKGROUND: Extensively drug-resistant (XDR) Pseudomonas aeruginosa and Acinetobacter baumannii are a threat to hospitalized patients. We evaluated the effects of antimicrobial combinations on XDR P. aeruginosa and A. baumannii isolates. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Genetic Basis of Multidrug-resistant Acinetobacter baumannii Clinical Isolates from Three University Hospitals in Chungcheong Province, Korea
-
Koo SH, Kwon KC, Cho HH, Sung JY
- KMID: 1022041
- Korean J Lab Med.
- 2010 Oct;30(5):498-506.
- doi: 10.3343/kjlm.2010.30.5.498
BACKGROUND: The emergence of multidrug-resistant (MDR) Acinetobacter baumannii as an important opportunistic pathogen has given rise to significant therapeutic challenges in the treatment of nosocomial infections. In the present study,... -
- CITED
-
- Close
- SHARE
-
- Close
- In vitro Antimicrobial Synergy against Imipenem-Resistant Acinetobacter baumannii
-
Sung H, Choi SJ, Yoo S, Kim MN
- KMID: 1781469
- Korean J Lab Med.
- 2007 Apr;27(2):111-117.
- doi: 10.3343/kjlm.2007.27.2.111
BACKGROUND: Most imipenem-resistant Acinetobacter baumannii (IRAB) isolates are multiresistant, leaving few options for an effective antimicrobial therapy. We purposed to select possible candidates for the combinations of antimicrobials that... -
- CITED
-
- Close
- SHARE
-
- Close
- Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control
-
Cheon S, Kim MJ, Yun SJ, Moon JY, Kim YS
- KMID: 2373812
- Korean J Intern Med.
- 2016 Mar;31(2):367-374.
- doi: 10.3904/kjim.2015.178
BACKGROUND/AIMS: Nosocomial infections caused by multidrug-resistant (MDR) Acinetobacter baumannii have become public-health problem. However, few studies have evaluated the control of endemic MDR A. baumannii in Intensive Care Units (ICUs).... -
- CITED
-
- Close
- SHARE
-
- Close
- Clonal Spread of Carbapenem Non-susceptible Acinetobacter baumannii in an Intensive Care Unit in a Teaching Hospital in China
-
Zhong Q, Xu W, Wu Y, Xu H
- KMID: 2434482
- Ann Lab Med.
- 2012 Nov;32(6):413-419.
BACKGROUND: This study was aimed to investigate the genetic diversity and antibiotic resistance profile of the nosocomial infection agent Acinetobacter baumannii from a medical intensive care unit (ICU) in a... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for Occurrence and 30-Day Mortality for Carbapenem-Resistant Acinetobacter baumannii Bacteremia in an Intensive Care Unit
-
Kim SY, Jung JY, Kang YA, Lim JE, Kim EY, Lee SK, Park SC, Chung KS, Park BH, Kim YS, Kim SK, Chang J, Park MS
- KMID: 1714208
- J Korean Med Sci.
- 2012 Aug;27(8):939-947.
- doi: 10.3346/jkms.2012.27.8.939
To assess the risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bacteremia and for 30-day mortality in patients with CRAB bacteremia in the intensive care unit (ICU), we conducted a retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Outbreaks of Imipenem Resistant Acinetobacter Baumannii Producing OXA-23 beta-Lactamase in a Tertiary Care Hospital in Korea
-
Yang HY, Lee HJ, Suh JT, Lee KM
- KMID: 1777088
- Yonsei Med J.
- 2009 Dec;50(6):764-770.
- doi: 10.3349/ymj.2009.50.6.764
PURPOSE: Since November 2006, imipenem-resistant Acinetobacter baumannii isolates have increased in Kyung Hee University Hospital in Seoul, Korea. The purpose of this study was to determine the genetic basis and... -
- CITED
-
- Close
- SHARE
-
- Close
